Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Other
This study will look at blood and tissue samples from people with and without a condition linked to a virus called the Epstein Barr virus (EBV).
The Epstein Barr virus is a common virus that most adults carry without noticing any effects. It usually infects cells of the immune system called B cells. But in some rare cases, the EB virus can infect other immune system cells called T cells and natural killer (NK) cells. This can cause rare types of lymphomas and leukaemias, including a non Hodgkin lymphoma which develops outside the lymphatic system (extra nodal), and a leukaemia called ‘aggressive natural killer cell leukaemia’.
Recruitment start: 1 February 2008
Recruitment end: 31 March 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Claire Shannon-Lowe
Bloodwise
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Gregor Mackay Memorial Fund
NIHR Clinical Research Network: Cancer
University of Birmingham
Last reviewed: 6 April 2021
CRUK internal database number: 4059